GlassScriptPhysician profile
Allan E Peljovich
NPI 1235187790
$1,431.47
in general payments reported to CMS, 2019-2025
9 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $58.05 · 2021: $15.43 · 2022: $59.69 · 2023: $94.48 · 2024: $24.72 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $585 · Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $585.16 |
| Food and Beverage | $548.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $899.95 | 2020-2025 | Checkpoint Stimulators |
| Biocircuit Technologies INC | $152.71 | 2025 | Nerve Tape |
| Acumed LLC | $149.43 | 2019 | |
| Anika Therapeutics, INC. | $94.48 | 2023 | Tactoset |
| Innovation Technologies INC | $59.69 | 2022 | |
| Sanara Medtech INC. | $24.72 | 2024 | Celleraterx |
| Axogen | $19.86 | 2025 | Axoguard Ha+ Nerve Protector |
| Endo Pharmaceuticals INC. | $15.43 | 2021 | |
| Baxter Healthcare | $15.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Peljovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.